Showing results (151-160 of 271) with videos related to
Sort By:
Pageof 28
AIDS and Behavior|July 30, 2024
Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational StudyMattia Trunfio, Elisa Vuaran, Daniela Vai, et al.Viruses|September 28, 2023
Increasing Neuroinflammation Relates to Increasing Neurodegeneration in People with HIVAzin Tavasoli, Benjamin B Gelman, Christina M Marra, et al.Journal of Neurovirology|July 13, 2019
Plasma (1 → 3)-β-D-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysisSara Gianella, Scott L Letendre, Jennifer Iudicello, et al.AIDS (London, England)|February 18, 2015
Antiretroviral therapy reduces neurodegeneration in HIV infectionAlex K Bryant, Ronald J Ellis, Anya Umlauf, et al.AIDS (London, England)|July 23, 2020
Antiretroviral drug concentrations in brain tissue of adult decedentsMicol Ferrara, Namandjé N Bumpus, Qing Ma, et al.Viruses|March 30, 2023
The Combined Effects of Cannabis, Methamphetamine, and HIV on NeurocognitionJeffrey M Rogers, Jennifer E Iudicello, Maria Cecilia G Marcondes, et al.Virology|December 23, 2008
Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populationsDavey M Smith, Selene Zárate, Hai Shao, et al.Annals of Clinical and Translational Neurology|July 4, 2020
Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIVRonald J Ellis, Monica Diaz, Ned Sacktor, et al.Plos One|June 14, 2016
Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive ImpairmentArvid Edén, Thomas D Marcotte, Robert K Heaton, et al.Brain, Behavior, & Immunity - Health|November 28, 2022
Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIVRowan Saloner, Ni Sun-Suslow, Erin E Morgan, et al.Pageof 28